{"id":58192,"date":"2024-08-12T12:03:51","date_gmt":"2024-08-12T12:03:51","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/08\/12\/4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference\/"},"modified":"2024-08-12T12:03:51","modified_gmt":"2024-08-12T12:03:51","slug":"4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference\/","title":{"rendered":"4DMT to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference"},"content":{"rendered":"<div>\n<p align=\"left\">EMERYVILLE, Calif., Aug.  12, 2024  (GLOBE NEWSWIRE) &#8212; 4D Molecular Therapeutics\u00a0(Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat large market diseases, today announced\u00a0that management will participate in a fireside chat at the H.C. Wainwright 4<sup>th<\/sup>\u00a0Annual Ophthalmology Virtual Conference.\u00a0Members of the management team will also be available for one-on-one meetings.<\/p>\n<p><strong>H.C. Wainwright 4<\/strong><sup><strong>th<\/strong><\/sup><strong> Annual Ophthalmology Virtual Conference<\/strong><\/p>\n<table style=\"border-collapse: collapse; width:100%; border-collapse:collapse ;\">\n<tr>\n<td style=\"max-width:20%; width:20%; min-width:20%;;vertical-align: top ; \">Presentation Date:<\/td>\n<td style=\"max-width:80%; width:80%; min-width:80%;;vertical-align: top ; \">Thursday, August 15, 2024<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top ; \">Presentation Time:<\/td>\n<td style=\"vertical-align: top ; \">12:00 p.m. ET<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top ; \">Webcast Link:<\/td>\n<td style=\"vertical-align: top ; \"><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PSwn_OiL2iqnJsJLXddW6Kv1rs9EELVksXkBJGayBtVJ1MWfAVUGpRUjBRq4mKydEsswWlxJ-GCXwF-RPUJYHVOceMNziWokdV8HNzDlZdAuGMAtY7Ysg8aG93i7F5au\" rel=\"nofollow noopener\" target=\"_blank\" title=\"Webcast\">Webcast<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>An archived copy of the webcast will be available for up to one year by visiting the \u201cInvestors\u201d section of the 4DMT website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1LLutp5i0iV5lwmyMef1TyeKIkSzsz4K7_Ddy_VFBTJgtrwNshj6SU_eaGAq9pS-sYYESn880xMDL9cEHJ0ebpP78OkFgcw5u17aoD93AmsF0j5mnxRG2ym135IVBBeEV3Hn4nb8lPsv_SW7IWqqrFS450T1U0vBeieNkg8H-Lw=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\">https:\/\/ir.4dmoleculartherapeutics.com\/events<\/a>.<\/p>\n<p><strong>About 4DMT<\/strong><\/p>\n<p>4DMT is a leading clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat large market diseases in ophthalmology and pulmonology. 4DMT\u2019s proprietary invention platform, Therapeutic Vector Evolution, combines the power of the Nobel Prize-winning technology, directed evolution, with approximately one billion synthetic AAV capsid-derived sequences to invent customized and evolved vectors for use in our wholly owned and partnered product candidates. Our product design, development, and manufacturing engine helps us efficiently create and advance our diverse product pipeline with the goal of revolutionizing medicine with potential curative therapies for millions of patients. Currently, 4DMT is advancing six clinical-stage and one preclinical product candidate, each tailored to address rare and large market diseases in ophthalmology, pulmonology and cardiology. In addition, 4DMT is also advancing programs in CNS through a gene editing partnership. 4D Molecular Therapeutics&#x2122;, 4DMT&#x2122;, Therapeutic Vector Evolution&#x2122;, and the 4DMT logo are trademarks of 4DMT.<\/p>\n<p>All of our product candidates are in clinical or preclinical development and have not yet been approved for marketing by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. No representation is made as to the safety or effectiveness of our product candidates for the therapeutic uses for which they are being studied.<\/p>\n<p>Learn more at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DY0Lsp1bHpj4pawwopyFpQKnB3ooSBP1qBCg03h60xicRDmHtnyQZQ1sc_WcLktP9qf2XBjIfWCl98Wgmdtcag==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"www.4DMT.com\">www.4DMT.com<\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=k8K8f-s05Yc-37FzkJzJWUP3LidCNU2vfoqDfJs3deMaUbBvO9SRNLdlso_M7hWWvxTisOzYQ9BPLb1LEcdQFDqIybUa6fWjII6cOotv7MqlTnocBac3XCIbZeGw0xOa\" rel=\"nofollow noopener\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a>.<\/p>\n<p><strong>Contacts:<\/strong><\/p>\n<p><strong>Media:<\/strong><\/p>\n<p>Katherine Smith<br \/>Inizio Evoke Comms<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=g0RHjDqpOsiUvjxvpnIfmvkpf69VUMeG10Vy03OXfR-lZDxFegjWgu_V7D52dUe1fg3ErutmsIcHvz6521-rvJ-Y4T_h1V2uio0MA_6tgRyK2hdYDGbB2OkhqQFih6dU\" rel=\"nofollow noopener\" target=\"_blank\" title=\"Katherine.Smith@inizioevoke.com\">Katherine.Smith@inizioevoke.com<\/a><\/p>\n<p><strong>Investors:<\/strong><\/p>\n<p>Julian Pei<br \/>Head of Investor Relations and Corporate Finance<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IuLIte8_V0WO1rUOzkN4iteUZlYT6f9eEBUvKtTFUHTSDYDbiXZbWL9NvcyfUwriS7MyXQQnyZN8Mn-F7tRUo06BNUl7vQlkToH4XpEUR6BXRceNOatWTBkBcoUxzPGE\" rel=\"nofollow noopener\" target=\"_blank\" title=\"Investor.Relations@4DMT.com\">Investor.Relations@4DMT.com<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/Y2M5ODE1MDctMWRlYi00NTdhLTgwOTctMjBhNTA0MjZhY2E4LTEyMDE2Njk=\/tiny\/4D-Molecular-Therapeutics-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>EMERYVILLE, Calif., Aug. 12, 2024 (GLOBE NEWSWIRE) &#8212; 4D Molecular Therapeutics\u00a0(Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat large market diseases, today announced\u00a0that management will participate in a fireside chat at the H.C. Wainwright 4th\u00a0Annual Ophthalmology Virtual Conference.\u00a0Members of the [&#8230;]\n","protected":false},"author":1,"featured_media":58193,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-58192","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>4DMT to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"4DMT to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference\" \/>\n<meta property=\"og:description\" content=\"EMERYVILLE, Calif., Aug. 12, 2024 (GLOBE NEWSWIRE) &#8212; 4D Molecular Therapeutics\u00a0(Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage ge\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-12T12:03:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/08\/4D-Molecular-Therapeutics-Inc-1-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"4DMT to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference\",\"datePublished\":\"2024-08-12T12:03:51+00:00\",\"dateModified\":\"2024-08-12T12:03:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference\/\"},\"wordCount\":378,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference\/\",\"name\":\"4DMT to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2024-08-12T12:03:51+00:00\",\"dateModified\":\"2024-08-12T12:03:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"4DMT to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"4DMT to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference\/","og_locale":"en_US","og_type":"article","og_title":"4DMT to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference","og_description":"EMERYVILLE, Calif., Aug. 12, 2024 (GLOBE NEWSWIRE) &#8212; 4D Molecular Therapeutics\u00a0(Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage ge","og_url":"https:\/\/english.saigonbiz.com\/vn\/4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2024-08-12T12:03:51+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/08\/4D-Molecular-Therapeutics-Inc-1-1.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"4DMT to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference","datePublished":"2024-08-12T12:03:51+00:00","dateModified":"2024-08-12T12:03:51+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference\/"},"wordCount":378,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference\/","url":"https:\/\/english.saigonbiz.com\/vn\/4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference\/","name":"4DMT to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2024-08-12T12:03:51+00:00","dateModified":"2024-08-12T12:03:51+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/4dmt-to-participate-in-the-h-c-wainwright-4th-annual-ophthalmology-virtual-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"4DMT to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/58192","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=58192"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/58192\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/58193"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=58192"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=58192"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=58192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}